CHEST Guidelines--em-Decídetexto--em---Mobile-Cessation-Suppor

-em-Decídetexto--em---Mobile-Cessation-Suppor

Pdf Summary

The study "Mobile Cessation Support for Latino Adults Who Smoke" explores the effectiveness of a culturally adapted mobile health intervention, Decídetexto, compared to standard care for smoking cessation in Latino adults. Conducted between October 2018 and September 2021 in Kansas, New Jersey, and New York, the study involved 457 Latino adult smokers assigned to either the Decídetexto group or a control group. The primary measure was biochemically verified 7-day smoking abstinence at 24 weeks.<br /><br />The results showed that 14.4% of participants in the Decídetexto group achieved confirmed abstinence, compared to 9.2% in the standard care group, which was not statistically significant. However, self-reported abstinence was significantly higher in the Decídetexto group at both 12 weeks (37.1% vs. 17.5%) and 24 weeks (34.1% vs. 20.6%). Moreover, uptake of nicotine replacement therapy (NRT) was notably higher in the Decídetexto group, with 90.6% reporting usage for at least one day compared to 70.2% in standard care.<br /><br />Despite challenges like reduced sample size and disrupted biochemical validation due to the COVID-19 pandemic, the study suggests that Decídetexto can effectively increase self-reported smoking abstinence and NRT uptake among Latino adults. While the program did not significantly outperform standard care in verified abstinence, its culturally tailored approach shows promise for broader adoption in community settings to support smoking cessation in Latino populations. <br /><br />Overall, Decídetexto, supported by the National Cancer Institute, highlights the role of culturally sensitive interventions in addressing health disparities, providing encouragement for implementing similar strategies in diverse communities to reduce smoking-related health issues.

Keywords

Decídetexto

smoking cessation

Latino adults

mobile health intervention

culturally adapted

nicotine replacement therapy

self-reported abstinence

health disparities

National Cancer Institute

COVID-19 pandemic